NEUROTROPHIC KERATITIS
Clinical trials for NEUROTROPHIC KERATITIS explained in plain language.
Never miss a new study
Get alerted when new NEUROTROPHIC KERATITIS trials appear
Sign up with your email to follow new studies for NEUROTROPHIC KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
OXERVATE eye drops show lasting healing in rare eye disease Follow-Up
Disease control CompletedThis study followed 24 people with stage 1 neurotrophic keratitis, a rare eye condition where the cornea doesn't heal properly, to see if OXERVATE eye drops remain safe and effective over 30 months. Participants had already completed the earlier DEFENDO study. Researchers tracked…
Matched conditions: NEUROTROPHIC KERATITIS
Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New eye drop shows promise for rare corneal disease
Disease control CompletedThis study tested an eye drop called OXERVATE in 37 adults with stage 1 neurotrophic keratitis, a condition where the cornea loses feeling and doesn't heal properly. The treatment was given for 8 weeks, and patients were followed for 24 weeks to see if the cornea healed safely. T…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE4 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New eye drops aim to heal corneal nerve damage – first human safety trial complete
Symptom relief CompletedThis early-stage study tested the safety of STSP-0902 eye drops in 82 healthy adults aged 18 to 45. The goal was to see if the drops are safe and how they move through the body. This is the first step toward a possible treatment for neurotrophic keratitis, a rare condition where …
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE1 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC